Symbols / RNLXY $2.07 -7.59%
RNLXY Chart
About
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | 452.31M |
| Enterprise Value | 911.97M | Income | -20.40M | Sales | 3.00M |
| Book/sh | -0.02 | Cash/sh | 0.00 | Dividend Yield | — |
| Payout | — | Employees | 46 | IPO | — |
| P/E | — | Forward P/E | -10.89 | PEG | — |
| P/S | 150.77 | P/B | -98.57 | P/C | — |
| EV/EBITDA | -54.28 | EV/Sales | 303.99 | Quick Ratio | 0.90 |
| Current Ratio | 1.21 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -3.50 | EPS next Y | -0.19 | EPS Growth | — |
| Revenue Growth | 13.70% | Earnings | 2024-11-19 16:00 | ROA | -160.99% |
| ROE | — | ROIC | — | Gross Margin | 40.00% |
| Oper. Margin | -7.84% | Profit Margin | 0.00% | Shs Outstand | 218.51M |
| Shs Float | 353.96M | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 202.50 | 52W Low | 2.04 |
| Beta | 1.80 | Avg Volume | 2.85K | Volume | 3.10K |
| Target Price | — | Recom | None | Prev Close | $2.24 |
| Price | $2.07 | Change | -7.59% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.01
Latest analyst target
3. DCF / Fair value
$-0.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.01
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-07-12 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
- Aetna (RNLXY) to Scale Clinical Collaboration to 10 Hospitals, 5% Readmission Drop - Stock Titan ue, 18 Nov 2025 08
- Renalytix shares fall 25% as revenues miss expectations - Yahoo! Finance Canada Wed, 11 Feb 2026 08
- Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire Wed, 20 Nov 2024 08
- REG - Renalytix PLC - Additional Subscription for 11m Shares - TradingView Wed, 24 Sep 2025 07
- Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease - PR Newswire Mon, 15 Sep 2025 07
- RNLX - Renalytix plc American Depositary Shares Latest Stock News & Market Updates - Stock Titan Mon, 14 Sep 2020 20
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -288.99K | 0.00 | 0.00 | -361.38K |
| TaxRateForCalcs | 0.06 | 0.00 | 0.00 | 0.19 |
| NormalizedEBITDA | -16.80M | -28.20M | -37.32M | -50.79M |
| TotalUnusualItems | -4.50M | -14.80M | -4.39M | -1.90M |
| TotalUnusualItemsExcludingGoodwill | -4.50M | -14.80M | -4.39M | -1.90M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -20.40M | -45.50M | -45.61M | -45.28M |
| ReconciledDepreciation | 0.00 | 2.50M | 508.00K | 489.00K |
| ReconciledCostOfRevenue | 1.80M | 2.10M | 2.68M | 2.10M |
| EBITDA | -21.30M | -43.00M | -41.71M | -52.69M |
| EBIT | -21.30M | -45.50M | -42.22M | -53.18M |
| NetInterestIncome | -400.00K | -400.00K | -40.00K | 233.00K |
| InterestExpense | 500.00K | 0.00 | 2.00K | 3.00K |
| InterestIncome | 0.00 | 200.00K | 12.00K | 236.00K |
| NormalizedIncome | -16.19M | -30.70M | -41.22M | -43.74M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -20.40M | -45.50M | -45.61M | -45.28M |
| TotalExpenses | 20.20M | 32.80M | 45.62M | 56.15M |
| RentExpenseSupplemental | 400.00K | 300.00K | ||
| TotalOperatingIncomeAsReported | -17.20M | -30.50M | -42.22M | -53.18M |
| DilutedAverageShares | 2.16M | 1.64M | 1.46M | 1.43M |
| BasicAverageShares | 2.16M | 1.64M | 1.46M | 1.43M |
| DilutedEPS | -15.50 | -28.00 | -41.00 | -21.50 |
| BasicEPS | -15.50 | -28.00 | -39.00 | -21.50 |
| DilutedNIAvailtoComStockholders | -20.40M | -45.50M | -45.61M | -45.28M |
| NetIncomeCommonStockholders | -20.40M | -45.50M | -45.61M | -45.28M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | 0.00 | 0.00 |
| NetIncome | -20.40M | -45.50M | -45.61M | -45.28M |
| MinorityInterests | 0.00 | 611.00K | ||
| NetIncomeIncludingNoncontrollingInterests | -20.40M | -45.50M | -45.61M | -45.28M |
| NetIncomeContinuousOperations | -20.40M | -45.50M | -45.61M | -45.28M |
| TaxProvision | -1.40M | 0.00 | 2.00K | 25.00K |
| PretaxIncome | -21.80M | -45.50M | -45.60M | -45.25M |
| OtherNonOperatingIncomeExpenses | 249.00K | 656.00K | 131.00K | 981.00K |
| SpecialIncomeCharges | -3.50M | -10.50M | 0.00 | 0.00 |
| OtherSpecialCharges | 3.50M | -115.00K | -1.15M | |
| WriteOff | 0.00 | 1.91M | ||
| ImpairmentOfCapitalAssets | 0.00 | 10.50M | 0.00 | |
| NetNonOperatingInterestIncomeExpense | -400.00K | -400.00K | -40.00K | 233.00K |
| TotalOtherFinanceCost | -100.00K | 600.00K | 50.00K | |
| InterestExpenseNonOperating | 500.00K | 0.00 | 2.00K | 3.00K |
| InterestIncomeNonOperating | 0.00 | 200.00K | 12.00K | 236.00K |
| OperatingIncome | -17.20M | -30.50M | -42.22M | -53.18M |
| OperatingExpense | 18.40M | 30.70M | 42.94M | 54.06M |
| OtherOperatingExpenses | 10.31M | 7.06M | ||
| DepreciationAndAmortizationInIncomeStatement | 0.00 | 2.00M | 2.25M | 2.05M |
| DepreciationIncomeStatement | 0.00 | 2.00M | 2.25M | 2.05M |
| ResearchAndDevelopment | 900.00K | 5.10M | 14.30M | 14.65M |
| SellingGeneralAndAdministration | 5.30M | 11.50M | 28.66M | 39.52M |
| SellingAndMarketingExpense | 400.00K | 700.00K | ||
| GeneralAndAdministrativeExpense | 4.90M | 10.80M | 28.66M | 39.52M |
| GrossProfit | 1.20M | 200.00K | 720.00K | 874.00K |
| CostOfRevenue | 1.80M | 2.10M | 2.68M | 2.10M |
| TotalRevenue | 3.00M | 2.30M | 3.40M | 2.97M |
| OperatingRevenue | 3.00M | 2.30M | 3.40M | 2.97M |
| Line Item | 2024-06-30 | 2021-06-30 | ||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | 0.00 | ||
| OrdinarySharesNumber | 331.21M | 154.37M | 93.78M | 74.76M |
| ShareIssued | 331.21M | 154.37M | 93.78M | 74.76M |
| NetDebt | 4.70M | 3.80M | ||
| TotalDebt | 8.30M | 8.50M | 12.12M | 12.34M |
| TangibleBookValue | -7.00M | -9.00M | 6.97M | 30.61M |
| InvestedCapital | 1.30M | -500.00K | 18.91M | 42.95M |
| WorkingCapital | 1.00M | -5.00M | 10.75M | 32.98M |
| NetTangibleAssets | -7.00M | -9.00M | 6.97M | 30.61M |
| CapitalLeaseObligations | 0.00 | 0.00 | 171.00K | 0.00 |
| CommonStockEquity | -7.00M | -9.00M | 6.97M | 30.61M |
| TotalCapitalization | 1.30M | -4.70M | 14.45M | 38.29M |
| TotalEquityGrossMinorityInterest | -7.00M | -9.00M | 6.97M | 30.61M |
| StockholdersEquity | -7.00M | -9.00M | 6.97M | 30.61M |
| OtherEquityInterest | 17.70M | 14.50M | 11.95M | 4.94M |
| RetainedEarnings | -165.10M | -144.70M | -178.32M | -132.72M |
| AdditionalPaidInCapital | 141.30M | 121.80M | 186.46M | 164.01M |
| CapitalStock | 1.10M | 500.00K | 286.00K | 228.00K |
| CommonStock | 1.10M | 500.00K | 286.00K | 228.00K |
| TotalLiabilitiesNetMinorityInterest | 13.10M | 16.10M | 23.66M | 19.46M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 8.30M | 4.30M | 7.53M | 7.68M |
| OtherNonCurrentLiabilities | 53.00K | |||
| LongTermDebtAndCapitalLeaseObligation | 8.30M | 4.30M | 7.53M | 7.68M |
| LongTermCapitalLeaseObligation | 0.00 | 41.00K | 0.00 | 213.00K |
| LongTermDebt | 8.30M | 4.30M | 7.49M | 7.68M |
| CurrentLiabilities | 4.80M | 11.80M | 16.14M | 11.78M |
| OtherCurrentLiabilities | 100.00K | 10.00K | 12.00K | |
| CurrentDebtAndCapitalLeaseObligation | 0.00 | 4.20M | 4.59M | 4.66M |
| CurrentCapitalLeaseObligation | 0.00 | 0.00 | 130.00K | 0.00 |
| CurrentDebt | 0.00 | 4.20M | 4.46M | 4.66M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.87M | 1.44M | ||
| Payables | 2.70M | 2.80M | 2.94M | 2.51M |
| OtherPayable | 55.00K | 350.00K | ||
| TotalTaxPayable | 100.00K | 200.00K | 139.00K | 638.00K |
| AccountsPayable | 2.60M | 2.60M | 2.94M | 2.46M |
| TotalAssets | 6.10M | 7.10M | 30.63M | 50.06M |
| TotalNonCurrentAssets | 300.00K | 300.00K | 3.75M | 5.31M |
| OtherNonCurrentAssets | 100.00K | 100.00K | 1.10M | 1.19M |
| NonCurrentDeferredTaxesAssets | 0.00 | 7.10M | ||
| InvestmentinFinancialAssets | 698.00K | 1.46M | 2.74M | |
| AvailableForSaleSecurities | 698.00K | 1.46M | 2.74M | |
| LongTermEquityInvestment | 0.00 | 0.00 | 0.00 | 9.00K |
| InvestmentsinJointVenturesatCost | 0.00 | 9.00K | 0.00 | |
| InvestmentsInOtherVenturesUnderEquityMethod | 9.00K | 0.00 | ||
| InvestmentsinSubsidiariesatCost | 0.00 | 0.00 | 0.00 | 0.00 |
| GoodwillAndOtherIntangibleAssets | 0.00 | 0.00 | 14.02M | 18.02M |
| OtherIntangibleAssets | 14.02M | 18.02M | ||
| NetPPE | 200.00K | 200.00K | 1.19M | 1.37M |
| AccumulatedDepreciation | -300.00K | -300.00K | -850.00K | -509.00K |
| GrossPPE | 500.00K | 500.00K | 2.04M | 1.88M |
| ConstructionInProgress | 0.00 | 0.00 | ||
| OtherProperties | 200.00K | 200.00K | 1.14M | 1.14M |
| MachineryFurnitureEquipment | 500.00K | 500.00K | 159.00K | 159.00K |
| BuildingsAndImprovements | 0.00 | 0.00 | 735.00K | 576.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 5.80M | 6.80M | 26.88M | 44.75M |
| OtherCurrentAssets | 100.00K | 100.00K | 1.42M | 2.44M |
| AssetsHeldForSaleCurrent | 0.00 | |||
| CurrentDeferredAssets | 36.00K | 0.00 | ||
| PrepaidAssets | 600.00K | 300.00K | 1.26M | 606.00K |
| Inventory | 200.00K | 300.00K | 1.16M | 353.00K |
| FinishedGoods | 200.00K | 300.00K | 1.16M | 353.00K |
| OtherReceivables | 75.00K | 76.00K | ||
| TaxesReceivable | 600.00K | 0.00 | ||
| AccountsReceivable | 600.00K | 700.00K | 776.00K | 901.00K |
| AllowanceForDoubtfulAccountsReceivable | -100.00K | -100.00K | ||
| GrossAccountsReceivable | 822.00K | 876.00K | 901.00K | |
| CashCashEquivalentsAndShortTermInvestments | 3.70M | 5.40M | 24.68M | 41.33M |
| OtherShortTermInvestments | 100.00K | 700.00K | 2.74M | 9.29M |
| CashAndCashEquivalents | 3.60M | 4.70M | 24.68M | 41.33M |
| CashFinancial | 3.60M | 4.70M | 24.68M | 41.33M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -17.90M | -29.80M | -34.09M | -46.59M |
| RepaymentOfDebt | -3.50M | -1.70M | -3.18M | 0.00 |
| IssuanceOfDebt | 0.00 | 18.02M | 0.00 | |
| IssuanceOfCapitalStock | 19.50M | 11.90M | 20.56M | 9.21M |
| CapitalExpenditure | -4.00K | -662.00K | -1.63M | |
| EndCashPosition | 3.60M | 4.70M | 24.68M | 41.33M |
| BeginningCashPosition | 4.70M | 24.70M | 41.33M | 65.13M |
| EffectOfExchangeRateChanges | 800.00K | -300.00K | 1.05M | -2.84M |
| ChangesInCash | -1.90M | -19.70M | -17.70M | -20.96M |
| FinancingCashFlow | 16.00M | 10.00M | 16.39M | 25.63M |
| NetCommonStockIssuance | 19.50M | 11.90M | 20.56M | 9.21M |
| CommonStockIssuance | 19.50M | 11.90M | 20.56M | 9.21M |
| NetIssuancePaymentsOfDebt | -3.50M | -1.70M | -3.18M | 18.02M |
| NetLongTermDebtIssuance | -3.50M | -1.70M | -3.18M | 18.02M |
| LongTermDebtPayments | -3.50M | -1.70M | -3.18M | 0.00 |
| LongTermDebtIssuance | 0.00 | 18.02M | 0.00 | |
| InvestingCashFlow | 0.00 | 100.00K | 0.00 | -662.00K |
| NetOtherInvestingChanges | -96.00K | |||
| InterestReceivedCFI | 0.00 | 3.00K | ||
| NetInvestmentPurchaseAndSale | 0.00 | 100.00K | 0.00 | 982.00K |
| SaleOfInvestment | 0.00 | 100.00K | 0.00 | 1.00M |
| PurchaseOfInvestment | 0.00 | 0.00 | ||
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | 0.00 | -62.00K |
| PurchaseOfBusiness | 0.00 | 0.00 | 0.00 | -62.00K |
| NetIntangiblesPurchaseAndSale | 0.00 | -105.00K | -847.00K | |
| PurchaseOfIntangibles | 0.00 | -105.00K | -847.00K | |
| NetPPEPurchaseAndSale | -4.00K | 0.00 | -557.00K | -783.00K |
| PurchaseOfPPE | -4.00K | 0.00 | -557.00K | -783.00K |
| OperatingCashFlow | -17.90M | -29.80M | -34.09M | -45.92M |
| InterestReceivedCFO | 3.00K | |||
| ChangeInWorkingCapital | -3.30M | -3.30M | 5.75M | -192.00K |
| ChangeInOtherCurrentLiabilities | 0.00 | -53.00K | 53.00K | |
| ChangeInOtherCurrentAssets | 0.00 | 29.00K | -75.00K | 122.00K |
| ChangeInAccruedExpense | -4.05M | 3.85M | -234.00K | 4.94M |
| ChangeInPayable | -2.70M | -4.00M | 448.00K | 1.96M |
| ChangeInPrepaidAssets | -800.00K | 200.00K | 1.30M | -1.49M |
| ChangeInInventory | 100.00K | 400.00K | -807.00K | -27.00K |
| ChangeInReceivables | 100.00K | 100.00K | 125.00K | -307.00K |
| OtherNonCashItems | 3.90M | 3.80M | 51.00K | -4.12M |
| StockBasedCompensation | 3.20M | 1.10M | 2.93M | 4.62M |
| DepreciationAndAmortization | 0.00 | 2.50M | 508.00K | 489.00K |
| AmortizationCashFlow | 0.00 | 2.30M | 2.31M | 1.96M |
| Depreciation | 200.00K | 508.00K | 489.00K | 138.00K |
| GainLossOnInvestmentSecurities | 500.00K | 600.00K | 3.28M | 5.90M |
| NetForeignCurrencyExchangeGainLoss | -400.00K | -200.00K | -1.01M | -7.34M |
| GainLossOnSaleOfBusiness | 0.00 | 0.00 | -46.00K | |
| NetIncomeFromContinuingOperations | -21.80M | -45.50M | -45.61M | -45.28M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for RNLXY
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|